Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. May 14, 2018. Omar Ishrak.

Executive Summary

Company stock will make up the "vast majority" of Mike Weinstein's compensation for being Medtronic's new senior VP of strategy. CEO Omar Ishrak said Medtronic's evolving executive compensation policies are an element of the firm's efforts to improve value to shareholders. See what Ishrak said about it here.

"We have changed our executive compensation fairly deep in our organization to reflect the sense of urgency we have about creating free cash flow. Executive compensation does drive behavior, does drive priorities and clarifies those priorities. And Mike choosing to be paid largely in Medtronic stock is a big signal as to what we can do and the confidence we have with respect to shareholder value." –Omar Ishrak, CEO, Medtronic

Click here for a free trial of Medtech Insight

Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT122661

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel